{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T15:15:11Z","timestamp":1789917311109,"version":"4.0.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2000,11,1]],"date-time":"2000-11-01T00:00:00Z","timestamp":973036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T00:00:00Z","timestamp":1577145600000},"content-version":"vor","delay-in-days":6992,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2000,11]]},"DOI":"10.1023\/a:1026586629166","type":"journal-article","created":{"date-parts":[[2003,11,6]],"date-time":"2003-11-06T12:11:16Z","timestamp":1068120676000},"page":"1501-1502","source":"Crossref","is-referenced-by-count":25,"title":["Interferon-\u03b1 induced Raynaud's syndrome"],"prefix":"10.1016","volume":"11","author":[{"given":"W.H.J.","family":"Kruit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.M.","family":"Eggermont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Stoter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1023\/A:1026586629166_bb0060","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2165\/00002018-199410020-00003","article-title":"Clinical toxicity of the interferons","volume":"10","author":"Vial","year":"1994","journal-title":"Drug Safety"},{"key":"10.1023\/A:1026586629166_bb0065","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/S0140-6736(88)91759-X","article-title":"Raynaud\u2019s phenomenon and cryoglobuli-naemia associated with the use of recombinant human alpha-mterferon","volume":"li","author":"Roy","year":"1988","journal-title":"Lancet"},{"key":"10.1023\/A:1026586629166_bb0070","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/0002-9343(92)90792-A","article-title":"Digital vasculitis associated with interferon therapy","volume":"92","author":"Reid","year":"1992","journal-title":"Am J Med"},{"key":"10.1023\/A:1026586629166_bb0075","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2796.1994.tb01111.x","article-title":"Raynaud\u2019s phe\u00acnomenon associated with alfa-interferon therapy","volume":"235","author":"Arslan","year":"1994","journal-title":"J Intern Med"},{"key":"10.1023\/A:1026586629166_bb0080","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/000331979604700210","article-title":"Severe Raynaud\u2019s syndrome associated with interferon therapy","volume":"47","author":"Creutzig","year":"1996","journal-title":"Angiology"},{"key":"10.1023\/A:1026586629166_bb0085","doi-asserted-by":"crossref","first-page":"423","DOI":"10.7326\/0003-4819-125-5-199609010-00025","article-title":"The Raynaud phenomenon and interferon therapy","volume":"125","author":"Creutzig","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1023\/A:1026586629166_bb0090","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0248-8663(97)84017-9","article-title":"Syndrome de Raynaud complique de gangrene digitale au cours D\u2019un traitement par l\u2019interferon alpha","volume":"18","author":"Liozon","year":"1997","journal-title":"Rev Med Interne"},{"key":"10.1023\/A:1026586629166_bb0095","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000040874","article-title":"Interferon-induced vaso\u00acspasm in chronic myeloid leukemia","volume":"100","author":"Zeidman","year":"1998","journal-title":"Acta Haematol"},{"key":"10.1023\/A:1026586629166_bb0100","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1177\/000331979504601210","article-title":"Interferon-induced coronary vasospasm; a case history","volume":"46","author":"Tanaka","year":"1995","journal-title":"Angiology"},{"key":"10.1023\/A:1026586629166_bb0105","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/112067219500500413","article-title":"Bilateral transient visual obscurations with headaches during alpha-II interferon therapy: A case report","volume":"5","author":"Detry-Morel","year":"1995","journal-title":"Eur J Opthalmol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419557155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419557155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/11\/11\/1501\/19478051\/11-11-1501.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T02:21:57Z","timestamp":1582165317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419557155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,11]]},"references-count":10,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2000,11]]}},"alternative-id":["S0923753419557155"],"URL":"https:\/\/doi.org\/10.1023\/a:1026586629166","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2000,11]]}}}